BBIO – Encaleret – Non-surgical Hypoparathyroidism – ENDO 2025 – Findings from Sponsored Genetic Testing Program Show Gain-of-function CASR Variants Identified as a Major[...]

BridgeBio Pharma Inc. published this content on July 12, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 12, 2025 at 19:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io